Retatrutide is a peptide studied for its activity at three hormone receptors: GLP-1, GIP and glucagon.
GLP-1 signalling is involved in appetite, feelings of fullness, gastric emptying and insulin release. GIP also influences insulin release and the body’s response to glucose. Glucagon signalling plays a role in blood sugar regulation and energy use.
Commonly Reported Areas of Interest
* Appetite regulation and reduced food cravings
* Weight-management research
* Improved feelings of fullness after eating
* Glucose and metabolic-health research
* Energy expenditure and fat-metabolism studies
* Combined GLP-1, GIP and glucagon receptor activity
These effects are not established clinical benefits. Most supporting evidence comes from laboratory and animal studies, while reliable human research remains extremely limited.
For research use only. Not for human consumption.
Retatrutide is a peptide studied for its activity at three hormone receptors: GLP-1, GIP and glucagon.
GLP-1 signalling is involved in appetite, feelings of fullness, gastric emptying and insulin release. GIP also influences insulin release and the body’s response to glucose. Glucagon signalling plays a role in blood sugar regulation and energy use.
Commonly Reported Areas of Interest
* Appetite regulation and reduced food cravings
* Weight-management research
* Improved feelings of fullness after eating
* Glucose and metabolic-health research
* Energy expenditure and fat-metabolism studies
* Combined GLP-1, GIP and glucagon receptor activity
These effects are not established clinical benefits. Most supporting evidence comes from laboratory and animal studies, while reliable human research remains extremely limited.
For research use only. Not for human consumption.
